Quest Diagnostics raises FY2020 outlook

 

• For FY2020, Quest Diagnostics (NYSE:DGX) now expects diluted EPS to be at least $9.98 vs. previous outlook of $8.22-$9.22; Adjusted diluted EPS to be at least $10.75 vs. prior outlook of $9-$10 and consensus of $9.90.
• The company expects cash from operations to be at least $1.95B above previous outlook of at least $1.75B and Capex to be ~$420M above prior outlook of ~$400M for the fiscal year.
• Press release
• https://seekingalpha.com/news/3644781-quest-diagnostics-raises-fy2020-outlook